Contineum Therapeutics, Inc. (CTNM) › EPS (Diluted)Contineum Therapeutics, Inc. (CTNM) — EPS (Diluted)Annual figures by fiscal year, from SEC filings.2023: $0.082024: $-2.182025: $-2.17$-2.172023EPS (Diluted) (USD/shares)2025Fiscal YearEPS (Diluted)Change YoY2025$-2.17+0.5%2024$-2.18-2825.0%2023$0.08—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeTotal AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share